Request for Proposals: Advancing Research for Treatments and Cures in GRI Disorders
Share This Post
CureGRIN Foundation is announcing an opportunity for funding to support research focused on treatments and cures for disorders associated with genetic mutations in ionotropic glutamate receptors (iGluRs) including GRIN, GRIA, GRIK and GRID genes (GRI Disorders). This award may support laboratory supplies, personnel costs, services, or the purchase of equipment necessary to conduct the proposed research.
Detailed Research Funding Announcement
The deadline to submit applications is February 15, 2025.
Duration and Budget
- Maximum total costs of $25,000. CureGRIN Foundation does not pay indirect costs.
- CureGRIN welcomes collaborations between labs (eg. for multiple $25,000 grants) as long as each project could stand on its own if it were the only funded project.
- CureGRIN Foundation does not pay indirect costs.
If you have any questions about this RFP, please contact CureGRIN Research Manager Meagan Hutchinson at meagan@curegrin.org
Read more Posts
Introducing GRIN Therapeutics
We recently announced plans to initiate the first clinical study on Radiprodil. Meet the GRIN Therapeutics team here.
Scientists: We want to fund your research towards treatments and cures
CureGRIN is now accepting applications for research funding that will help advance and accelerate our search for treatments and cures for GRI Disorder (GRIN, GRIA, GRIK and GRID).
